0.25% -0.02

Kalvista Pharmaceuticals Inc (KALV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Kalvista Pharmaceuticals Inc Azioni (KALV) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	28.16% 55.03	42.94	45.81	44.22	48.45
Operating Income/Loss	28.16% -55.03	-42.94	-45.81	-44.22	-48.45
Nonoperating Income/Loss	247.43% 1.949	-1.322	3.543	3.772	3.806
Income/Loss From Continuing Operations Before Tax	19.92% -53.08	-44.26	-42.27	-40.44	-44.65
Income Tax Expense/Benefit	120.13% -0.855	4.247	-	-	-
Income/Loss From Continuing Operations After Tax	7.66% -52.23	-48.51	-42.27	-40.44	-44.65
Net Income/Loss	7.66% -52.23	-48.51	-42.27	-40.44	-44.65
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	97.85% 1.1305	52.64	46.70	46.23	2.2187
Diluted Average Shares	97.85% 1.1305	52.64	46.70	46.23	2.2187
Basic Earnings Per Share	7.61% -0.99	-0.92	-0.91	-0.87	-1.07
Diluted Earnings Per Share	7.61% -0.99	-0.92	-0.91	-0.87	-1.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$20.66

2.36%

INCY

$84.81

1.10%

GMAB

$30.67

4.57%

BNTX

$98.62

0.53%

INSM

$144.01

1.67%

ONC

$340.70

2.36%